http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101626683-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 |
| filingDate | 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101626683-B |
| titleOfInvention | Be used for the treatment of compound and the pharmaceutical composition of virus infection |
| abstract | There is provided herein and be used for the treatment of liver disorders and comprise the compound of HCV and/or HBV infection, composition and method.Particularly, disclosed herein is nucleoside derivates compound and composition, they can be used separately or co-administered with other antiviral agent. |
| priorityDate | 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 890.